GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (XCNQ:MMEN) » Definitions » EV-to-EBIT

MedMen Enterprises (XCNQ:MMEN) EV-to-EBIT : -2.94 (As of Jun. 20, 2024)


View and export this data going back to 1987. Start your Free Trial

What is MedMen Enterprises EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MedMen Enterprises's Enterprise Value is C$524.8 Mil. MedMen Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was C$-178.5 Mil. Therefore, MedMen Enterprises's EV-to-EBIT for today is -2.94.

The historical rank and industry rank for MedMen Enterprises's EV-to-EBIT or its related term are showing as below:

XCNQ:MMEN's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.03
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MedMen Enterprises's Enterprise Value for the quarter that ended in Mar. 2023 was C$-120.4 Mil. MedMen Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was C$-178.5 Mil. MedMen Enterprises's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 was 148.29%.


MedMen Enterprises EV-to-EBIT Historical Data

The historical data trend for MedMen Enterprises's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises EV-to-EBIT Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,431.07 -2.67 -0.57 -2.16 0.05

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.35 0.05 0.62 0.87 0.67

Competitive Comparison of MedMen Enterprises's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's EV-to-EBIT falls into.



MedMen Enterprises EV-to-EBIT Calculation

MedMen Enterprises's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=524.788/-178.499
=-2.94

MedMen Enterprises's current Enterprise Value is C$524.8 Mil.
MedMen Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-178.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMen Enterprises  (XCNQ:MMEN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MedMen Enterprises's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2023 ) =EBIT / Enterprise Value (Q: Mar. 2023 )
=-178.499/-120.369
=148.29 %

MedMen Enterprises's Enterprise Value for the quarter that ended in Mar. 2023 was C$-120.4 Mil.
MedMen Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-178.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMen Enterprises EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (XCNQ:MMEN) Business Description

Traded in Other Exchanges
N/A
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises (XCNQ:MMEN) Headlines

No Headlines